Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) clinical trial (NCT04770753). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) clinical trial (NCT04770753). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) clinical trial (NCT04770753). Contact the study team or your healthcare provider for specific answers.

Question 4

What will happen if I experience side effects from the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) clinical trial (NCT04770753). Contact the study team or your healthcare provider for specific answers.

Question 5

How does mitapivat compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) clinical trial (NCT04770753). Contact the study team or your healthcare provider for specific answers.

What this study is about